Biocept Inc. (BIOCQ) — Cash Flow Reinvestment Rate

Latest as of December 2021: 0.85x

Biocept Inc. (BIOCQ) has a Cash Flow Reinvestment Rate of 0.85x as of December 2021, reinvesting $3.14 Million (capex $1.57 Million plus investments $-1.57 Million) from operating cash flow of $3.69 Million. Explore BIOCQ cash generation efficiency to assess how effectively this company generates cash.

Reinvestment Rate

0.85x
(Capex + Investments) / Operating CF

Total Reinvested

$3.14 Million
Capex + Investments

Operating Cash Flow

$3.69 Million
USD

Capital Expenditures

$1.57 Million
USD

Biocept Inc. Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Biocept Inc. across 1 annual periods. Explore cash flow to debt ratio of Biocept Inc. to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Biocept Inc. (2021–2021)

Year-by-year capital reinvestment analysis for Biocept Inc.. For live market cap and broader valuation context, see BIOCQ stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.85x $3.14 Million $3.69 Million $1.57 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow